Vitality Watch

⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.

Mentioned 12× · first seen 09-sep-2026 · last seen 13-nov-2026

Fisetin

Current understanding

To be populated as evidence accumulates.

Evidence log

Open questions

Related

Contributing findings

pubmed review
Senescence-Associated Secretory Phenotype (SASP) and Atherosclerotic Plaque Inflammation: Natural Product-Based Interventions and Implications for Personalized Therapy.
10-nov-2026 novelty 2 per-area 2 strengthens
pubmed review
Is there a role for senotherapeutics in the treatment of giant cell arteritis?
07-oct-2026 novelty 2 per-area 2 mentions
rss preclinical animal-model
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan
06-oct-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
Novel Flavonoid Senotherapeutics Identified by Phenotypic Drug Discovery Reduce Senescence and Improve Multiple Markers of Healthspan.
01-oct-2026 novelty 3 per-area 3 strengthens
clinicaltrials trial early expert-opinion
An Open-Label Intervention Trial to Reduce Senescence and Improve Frailty in Adult Survivors of Childhood Cancer
30-sep-2026 novelty 3 per-area 3 strengthens
pubmed preclinical mechanism-plausible
Discovery of Fisetin as a potent and cell-active ACVR2A inhibitor.
27-sep-2026 novelty 3 per-area 3 strengthens
clinicaltrials trial early expert-opinion
Fisetin to Improve Vascular Function in Older Adults
25-sep-2026 novelty 3 per-area 3 strengthens
pubmed other
Retraction notice to "Fisetin as a caloric restriction mimetic protects rat brain against aging induced oxidative stress, apoptosis and neurodegeneration" [Life Sci. 193 (2018) 171-179].
23-sep-2026 novelty 2 per-area 2 weakens
pubmed review
Clinical Translation of Fisetin for Age-Related Diseases: Current Evidence and Future Opportunities.
14-sep-2026 novelty 2 per-area 2 strengthens
clinicaltrials trial early expert-opinion
Evaluation of Urolithin A and Fisetin on Improving Sleep and Aging Biomarkers
10-aug-2026 novelty 3 per-area 3 strengthens
pubmed review mechanism-plausible
Natural Bioactive Compounds Targeting Key Hallmarks of Aging: Functional Food Potential of Spermidine, Fisetin, Berberine, and Urolithin A.
03-aug-2026 novelty 3 per-area 3 strengthens
clinicaltrials trial early expert-opinion
Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
30-jul-2026 novelty 3 per-area 3 strengthens
clinicaltrials trial early expert-opinion
Ongoing Lung Decline With Age Intensified Response
01-jul-2026 novelty 3 per-area 3 strengthens
pubmed preclinical animal-model
A photo-responsive, fisetin-functionalized DNA nanocage for programmed therapy to accelerate early-stage wound healing in aged skin.
21-may-2026 novelty 3 per-area 3 strengthens

build build 880 · 2bcef25 · 2026-11-18